Algert Global LLC buys 13,879 shares of Masimo Co. (NASDAQ:MASI)

Algert Global LLC acquired a new stake in Masimo Co. (NASDAQ:MASI – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 13,879 shares of the medical equipment provider’s stock, valued at approximately $1,748,000.

A number of other large investors have also recently bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in Masimo by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 4,781,343 shares of the medical equipment provider’s stock valued at $560,421,000 after acquiring an additional 26,473 shares during the period. Capital Research Global Investors boosted its stake in shares of Masimo by 6.4% during the 4th quarter. Capital Research Global Investors now owns 2,269,189 shares of the medical equipment provider’s stock worth $265,972,000 after which bought another 136,617 shares during that period. Farallon Capital Management LLC boosted its stake in Masimo by 13.6% in the first quarter. Farallon Capital Management LLC now owns 1,489,563 shares of the medical equipment provider’s stock worth $218,742,000 after buying an additional 177,914 shares during the period. Thrivent Financial for Lutherans boosted its stake in Masimo by 42.1% in the second quarter. Thrivent Financial for Lutherans now owns 1,217,357 shares of the medical equipment provider’s stock worth $153,314,000 after buying an additional 360,497 shares during the period. Finally, Schroder Investment Management Group raised its stake in shares of Masimo by 59.6% during the 4th quarter. Schroder Investment Management Group now owns 877,539 shares of the medical equipment provider’s stock worth $102,856,000 after which bought another 327,863 shares during the period. 85.96% of shares are held by institutional investors and hedge funds.

Masimo stock 0.8%

Shares of MASI stock opened at $135.54 on Thursday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.15, and a current ratio of 2.09. Masimo Co. has a one year low of $75.22 and a one year high of $153.93. The stock has a market cap of $7.21 billion, a price-to-earnings ratio of 92.20 and a beta of 0.98. The stock has a 50-day moving average price of $118.73 and a 200-day moving average price of $125.00.

Masimo (NASDAQ:MASI – Get Your Free Report ) last posted its quarterly earnings results on Tuesday, August 6th. The medical equipment provider reported $0.86 EPS for the quarter, topping the consensus estimate of $0.77 by $0.09. The firm had revenue of $496.30 million during the quarter, compared to analysts’ expectations of $493.92 million. Masimo had a return on equity of 14.07% and a net margin of 3.94%. The company’s revenue for the quarter was up 9.0% year over year. In the same period last year, the company earned $0.62 per share. Equities research analysts forecast that Masimo Co. will post 3.87 earnings per share for the current fiscal year.

Analysts set new price targets

Several research analysts recently weighed in on MASI shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a research note on Friday, September 20th. Piper Sandler boosted their price target on Masimo from $160.00 to $165.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Moderate Buy” and an average price target of $144.67, according to MarketBeat .

Read our latest review of MASI

Masimo profile

(Free Report)

Masimo Corporation develops, manufactures and markets various patient monitoring technologies and automation and connectivity solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with motion measurement monitoring and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET pulse CO-Oximetry products that enable non-invasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiratory rate from pleth and oxygen reserve index, as well as acoustic breathing monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring and regional oximetry.

Further reading

Want to see what other hedge funds MASI owns? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Masimo Co. (NASDAQ:MASI – Free Report).

Get news and reviews for Masimo Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Masimo and related companies with MarketBeat.com’s FREE daily email newsletter.